Jove
Visualize
Contact Us

Related Experiment Videos

Lupus nephritis: a 13-year experience.

R J Walker, R R Bailey, C P Swainson

    The New Zealand Medical Journal
    |November 26, 1986
    PubMed
    Summary

    Systemic lupus erythematosus (SLE) with kidney disease often presents with proteinuria or hematuria. Renal biopsy is crucial for prognosis, with diffuse proliferative glomerulonephritis indicating a poor outlook.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Myocardial metastasis of cutaneous squamous cell carcinoma in a renal transplant recipient.

    Transplantation proceedings·2009
    Same author

    Diagnosis of aspergillus peritonitis in a renal dialysis patient by PCR and galactomannan detection.

    Journal of clinical pathology·2004
    Same author

    The NHS and leadership.

    Hospital medicine (London, England : 1998)·2003
    Same author

    Successful treatment of CAPD peritonitis caused by rhodotorula mucilaginosa.

    Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2002
    Same author

    Acute renal failure in a patient with paroxysmal nocturnal hemoglobinuria.

    Clinical nephrology·2001
    Same author

    Cost-benefit analysis and prediction of 24-hour proteinuria from the spot urine protein-creatinine ratio.

    Clinical nephrology·2001
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies

    Area of Science:

    • Nephrology
    • Rheumatology
    • Immunology

    Background:

    • Systemic lupus erythematosus (SLE) is an autoimmune disease that can affect multiple organs, including the kidneys.
    • Renal involvement is a common and serious complication of SLE, significantly impacting patient prognosis.
    • Renal biopsy is a key diagnostic tool for assessing lupus nephritis activity and guiding treatment.

    Purpose of the Study:

    • To analyze the clinical characteristics, renal biopsy findings, treatment, and outcomes of patients with SLE and renal disease.
    • To evaluate the prognostic value of renal biopsy in SLE patients with kidney involvement.
    • To determine the long-term renal survival rates in this patient cohort.

    Main Methods:

    • Retrospective analysis of 42 patients with SLE and biopsy-proven renal disease over a 13-year period.
    • Review of clinical data, including presenting symptoms, laboratory findings (proteinuria, hematuria), and treatment regimens (prednisone, azathioprine).
    • Correlation of renal biopsy findings (specifically diffuse proliferative glomerulonephritis) with clinical presentation, treatment response, and patient outcomes.

    Main Results:

    • Renal involvement was the initial manifestation in a significant proportion of patients, particularly men.
    • Proteinuria with or without hematuria was the most common indication for renal biopsy (23/42 patients).
    • Diffuse proliferative glomerulonephritis was diagnosed in 50% of patients and was associated with a poor prognosis, especially with renal insufficiency. A 5-year renal survival rate of 72% was observed.
    • Patients treated with prednisone and azathioprine showed varied responses, while those on dialysis/transplant became symptom-free.

    Conclusions:

    • Renal biopsy is essential for assessing SLE severity and predicting prognosis in patients with lupus nephritis.
    • Diffuse proliferative glomerulonephritis in SLE patients indicates a guarded prognosis, highlighting the need for timely and effective therapeutic interventions.
    • Management strategies, including immunosuppression and renal replacement therapy, play a critical role in improving long-term outcomes for patients with severe lupus nephritis.

    Related Experiment Videos